Pulmonary function in adolescents with ataxia telangiectasia

Pediatric Pulmonology

Volumn 43, Issue 1, 2008, Pages 59-66

  McGrath Morrow, Sharon ^a,c   Lefton Greif, Maureen ^a   Rosquist, Karen ^a   Crawford, Thomas ^a   Kelly, Amber ^a   Zeitlin, Pamela ^a   Carson, Kathryn A ^b   Lederman, Howard M ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Division of Pediatric Endocrinology   (United States)

Author keywords

Ataxia telangiectasia; Dysphagia I; Lung volumes; Spirometry

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATAXIA TELANGIECTASIA; BULBAR PARALYSIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL RESIDUAL CAPACITY; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG VOLUME; MALE; PATIENT MOBILITY; PATIENT POSITIONING; PRIORITY JOURNAL; REPRODUCIBILITY; RESIDUAL VOLUME; SPIROMETRY; TOTAL LUNG CAPACITY; TREMOR; VITAL CAPACITY;

ADOLESCENT; ADULT; ATAXIA TELANGIECTASIA; CHILD; FEMALE; HUMANS; LUNG; MALE; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS;

EID: 38349058629     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20738     Document Type: Article

References (30)

1. Kuhne M, Riballo E, Rief N, Rothkamm K, Jeggo PA, Lobrich M. A double-strand break repair defect in ATM-deficient cells contributes to radiosensitivity. Cancer Res 2004;64:500-508.
2. Crawford TO. Ataxia Telangiectasia. Semin Pediatr Neurol 1998;5:287-294.
3. Swift M, Morrell D, Cromartie E, Chamberlin AR, Skolnick MH, Bishop DT. The incidence and gene frequency of ataxia-telangiectasia in the United States. Am J Hum Genet 1986;39:573-583.
4. Claret TG, Giner Munoz MT, Plaza Martin AM, Martin Mateos MA, Piquer GM, Sierra Martinez JI. Variability of immunodeficiency associated with ataxia telangiectasia and clinical evolution in 12 affected patients. Pediatr Allergy Immunol 2005;16:615-618.
5. Crawford TO, Skolasky RL, Fernandez R, Rosquist KJ, Lederman HM. Survival probability in ataxia telangiectasia. Arch Dis Child 2006;91:610-611.
6. Schroeder SA, Swift M, Sandoval C, Langston C. Interstitial lung disease in patients with ataxia-telangiectasia. Pediatr Pulmonol 2005;39:537-543.
7. Sandoval C, Swift M. Hodgkin disease in ataxia-telangiectasia patients with poor outcomes. Med Pediatr Oncol 2003;40:162-166.
8. Lefton-Greif MA, Crawford TO, Winkelstein JA, Loughlin GM, Koerner CB, Zahurak M, Lederman HM. Oropharyngeal dysphagia and aspiration in patients with ataxia-telangiectasia. J Pediatr 2000;136:225-231.
9. Waite S, Jeudy J, White CS. Acute lung infections in normal and immunocompromised hosts. Radiol Clin North Am 2006;44:295-315 ix.
10. Pikus L, Levine MS, Yang YX, Rubesin SE, Katzka DA, Laufer I, et al. Videofluoroscopic studies of swallowing dysfunction and the relative risk of pneumonia. AJR Am J Roentgenol 2003;180:1613-1616.
11. Cabana MD, Crawford TO, Winkelstein JA, Christensen JR, Lederman HM. Consequences of the delayed diagnosis of ataxia-telangiectasia. Pediatrics 1998;102:98-100.
12. Ogden CL. Defining overweight in children using growth charts. Md Med 2004;5:19-21.
13. Blonshine S, Mattram C, Wagner J. ATS, Pulmonary Funciton Laboratory Management And Procedure Manual. 2nd. 2005.
14. Fleiss JL. The design and analysis of clinical experiments. New York: Wiley; 1999.
15. Pauwels JH, Van Bever HP, Desager KN, Willemen MJ, Creten WL, Van Acker KJ, et al. Functional residual capacity in healthy preschool children. Eur Respir J 1996;9:2224-2230.
16. Schroeder SA, Swift M, Sandoval C, Langston C. Interstitial lung disease in patients with ataxia-telangiectasia. Pediatr Pulmonol 2005;39:537-543.
17. Crawford TO, Mandir AS, Lefton-Greif MA, Goodman SN, Goodman BK, Sengul H, et al. Quantitative neurologic assessment of ataxia-telangiectasia. Neurology 2000;54:1505-1509.
18. Chen RL, Wang PJ, Hsu YH, Chang PY, Fang JS. Severe lung fibrosis after chemotherapy in a child with ataxia-telangiectasia. J Pediatr Hematol Oncol 2002;24:77-79.
19. Martinez FJ, Flaherty K. Pulmonary function testing in idiopathic interstitial pneumonias. Proc Am Thorac Soc 2006;3:315-321.
20. Chetta A, Marangio E, Olivieri D. Pulmonary function testing in interstitial lung diseases. Respiration 2004;71:209-213.
21. Wilson SH, Cooke NT, Edwards RH, Spiro SG. Predicted normal values for maximal respiratory pressures in Caucasian adults and children. Thorax 1984;39:535-538.
22. Domenech-Clar R, Lopez-Andreu JA, Compte-Torrero L, Diego-Damia A, Macian-Gisbert V, Perpina-Tordera M, et al. Maximal static respiratory pressures in children and adolescents. Pediatr Pulmonol 2003;35:126-132.
23. Sapienza CM, Wheeler K. Respiratory muscle strength training: functional outcomes versus plasticity. Semin Speech Lang 2006;27:236-244.
24. Ammann AJ, Duquesnoy RJ, Good RA. Endocrinological studies in ataxiatelangiectasia and other immunological deficiency diseases. Clin Exp Immunol 1970;6:587-595.
25. Toussaint M, Steens M, Soudon P. Lung function accurately predicts hypercapnia in patients with duchenne muscular dystrophy. Chest 2007;131:368-375.
26. Weiner P, Mcconnell A. Respiratory muscle training in chronic obstructive pulmonary disease: inspiratory, expiratory, or both? Curr Opin Pulm Med 2005;11:140-144.
27. Steier J, Kaul S, Seymour J, Jolley C, Rafferty GF, Man WD, et al. The value of multiple tests of respiratory muscle strength. Thorax 2007;62:975-980.
28. Silverman EP, Sapienza CM, Saleem A, Carmichael C, Davenport PW, Hoffman-Ruddy B, et al. Tutorial on maximum inspiratory and expiratory mouth pressures in individuals with idiopathic parkinson disease (IPD) and the preliminary results of an expiratory muscle strength training program. Neurorehabilitation 2006;21:71-79.
29. Weiner P, Magadle R, Beckerman M, Weiner M, Berar-Yanay N. Specific expiratory muscle training in COPD. Chest 2003;124:468-473.
30. Dohna-Schwake C, Ragette R, Teschler H, Voit T, Mellies U. Predictors of severe chest infections in pediatric neuromuscular disorders. Neuromuscul Disord 2006;16:325-328.